Stock Earnings

Question 1

Lexicon Pharmaceuticals Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Lexicon Pharmaceuticals Inc의 총 자산은 $298이며, 순loss입니다.

Question 2

LXRX의 주요 재무 비율은 무엇인가요?

Accepted Answer

Lexicon Pharmaceuticals Inc의 유동비율은 1.96이고, 순이익률은 -645.16, 주당 매출은 $0.09입니다.

Question 3

Lexicon Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Lexicon Pharmaceuticals Inc largest revenue segment is Pharmaceutical Products, at a revenue of 31,081,000 in the most earnings release.For geography, United States is the primary market for Lexicon Pharmaceuticals Inc, at a revenue of 31,081,000.

Question 4

Lexicon Pharmaceuticals Inc은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 Lexicon Pharmaceuticals Inc의 순loss은 $-200입니다.

Question 5

Lexicon Pharmaceuticals Inc에 부채가 있나요?

Accepted Answer

yes, Lexicon Pharmaceuticals Inc의 부채는 152입니다.

Question 6

Lexicon Pharmaceuticals Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Lexicon Pharmaceuticals Inc의 총 발행 주식은 361.49주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	58	31	1	0	0	24
Revenue Growth (YoY)	1,832.99%	3,000%	--	--	-100%	-93%
Cost of Revenue	0	0	0	0	0	1
Gross Profit	57	30	1	0	0	22
Selling, General & Admin	92	143	113	48	32	47
Research & Development	83	84	58	52	55	153
Operating Expenses	176	227	172	100	87	200
Other Non Operating Income (Expenses)	10	12	7	1	0	2
Pretax Income	-120	-200	-177	-101	-87	-58
Income Tax Expense	--	--	--	--	0	0
Net Income	-120	-200	-177	-101	-87	-58
Net Income Growth	-41%	13%	75%	16%	50%	-145%
Shares Outstanding (Diluted)	363.57	320.03	221.13	165.7	145.7	110.8
Shares Change (YoY)	17%	45%	33%	14%	32%	-5%
EPS (Diluted)	-0.33	-0.62	-0.8	-0.62	-0.6	-0.53
EPS Growth	-49%	-22%	28.99%	3%	13%	-148%
Free Cash Flow	-102	-179	-162	-90	-88	-143
Free Cash Flow Per Share	-0.28	-0.55	-0.73	-0.54	-0.6	-1.29
Gross Margin	98.27%	96.77%	100%	0%	0%	91.66%
Operating Margin	-203.44%	-635.48%	-17,100%	0%	0%	-741.66%
Profit Margin	-206.89%	-645.16%	-17,700%	0%	0%	-241.66%
Free Cash Flow Margin	-175.86%	-577.41%	-16,200%	0%	0%	-595.83%
EBITDA	-118	-197	-171	-100	-87	-176
EBITDA Margin	-203.44%	-635.48%	-17,100%	0%	0%	-733.33%
D&A For EBITDA	0	0	0	0	0	2
EBIT	-118	-197	-171	-100	-87	-178
EBIT Margin	-203.44%	-635.48%	-17,100%	0%	0%	-741.66%
Effective Tax Rate	--	--	--	--	0%	0%

Lexicon Pharmaceuticals Inc (LXRX) Price

LXRX Stock Price Chart

LXRX Income

Follow-Up Questions